Logo Image
News|Articles|January 27, 2015

PTSM: Pharmaceutical Technology Sourcing and Management

  • PTSM: Pharmaceutical Technology Sourcing and Management-02-04-2015
  • Volume 11
  • Issue 2

FUJIFILM Diosynth Begins Work on Bioprocess Innovation Center

The new facility will feature new research and development capabilities.


FUJIFILM Diosynth announced on Jan. 13, 2015 that the company is opening a new facility in Research Triangle Park, North Carolina. The new location, called the Bioprocess Innovation Center, will offers clients services in process invention and process and product characterization for its clients, according to a press release.

"The construction of this building reflects the continued commitment of our organization to provide our clients with the infrastructure to efficiently and innovatively bring their products to the clinic and beyond for the benefit of their patients," said Steve Bagshaw, CEO, FUJIFILM Diosynth Biotechnologies.

The three-story, 62,000-square-foot facility has an expected completion date in the fourth quarter of 2015.

Source:
FUJIFILM

Articles in this issue

over 11 years ago

Technology Improvements Drive Capacity Gains for Biologics Fill/Finish

over 11 years ago

New Excipient Options for Oral Solid Dosage Drugs

over 11 years ago

Extending Shelf Life through Better Blister Package Designs

over 11 years ago

More Growth Expected for API Custom Manufacturing in 2015

over 11 years ago

Catalent Expands High-Potency Handling Capability

over 11 years ago

PPD Announces Completion of Clinical Studies Facility in Ireland

over 11 years ago

Ash Stevens to Manufacture Amotosalen API

over 11 years ago

SAFC Expands Irvine Facility

over 11 years ago

AMRI Acquires Two Aptuit Facilities

Related Content